Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity

Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity

US Patent 8785488 · Granted Jul 22, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chiral synthesis of a tertiary alcohol2025
Chiral synthesis of a tertiary alcohol2025
NLRP3 modulators2025
Isoquinolin-3-yl carboxamides and preparation and use thereof2025
Salt form of estrogen receptor downregulator, crystalline form thereof, and prep2024
Substituted cyclohexyl compounds as NOP inhibitors2024
TYK2 pseudokinase ligands2023
Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands2023
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof2023
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors2023
NLRP3 modulators2023
Isoquinolin-3-yl carboxamides and preparation and use thereof2023